The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
In silico analysis of a multifactorial consensus signature (ConSig) for predicting response to anthracycline (A)-based neoadjuvant chemotherapy (NAC) in triple-negative breast cancer (TNBC) patients (pts).
Natalie Heather Turner
No relevant relationships to disclose
Mattia Forcato
No relevant relationships to disclose
Simona Nuzzo
No relevant relationships to disclose
Luca Malorni
No relevant relationships to disclose
Silvio Bicciato
No relevant relationships to disclose
Angelo Di Leo
No relevant relationships to disclose